GB2570113B - Ocular drug delivery system - Google Patents
Ocular drug delivery system Download PDFInfo
- Publication number
- GB2570113B GB2570113B GB1800385.5A GB201800385A GB2570113B GB 2570113 B GB2570113 B GB 2570113B GB 201800385 A GB201800385 A GB 201800385A GB 2570113 B GB2570113 B GB 2570113B
- Authority
- GB
- United Kingdom
- Prior art keywords
- delivery system
- drug delivery
- ocular drug
- ocular
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1800385.5A GB2570113B (en) | 2018-01-10 | 2018-01-10 | Ocular drug delivery system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1800385.5A GB2570113B (en) | 2018-01-10 | 2018-01-10 | Ocular drug delivery system |
Publications (3)
Publication Number | Publication Date |
---|---|
GB201800385D0 GB201800385D0 (en) | 2018-02-21 |
GB2570113A GB2570113A (en) | 2019-07-17 |
GB2570113B true GB2570113B (en) | 2022-03-16 |
Family
ID=61190424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1800385.5A Expired - Fee Related GB2570113B (en) | 2018-01-10 | 2018-01-10 | Ocular drug delivery system |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2570113B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111945302A (en) * | 2019-05-17 | 2020-11-17 | 安徽伊尔思环境科技有限公司 | Wastewater filtering fiber membrane |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1372604A2 (en) * | 2001-03-22 | 2004-01-02 | Battelle Memorial Institute | Manufacturing dissolvable dosage forms |
US20120148493A1 (en) * | 2009-03-16 | 2012-06-14 | Justus-Liebig-Universitat Giessen | Composite Materials Loaded with Therapeutic and Diagnostic Agents Comprising Polymer Nanoparticles and Polymer Fibers |
WO2014190038A2 (en) * | 2013-05-22 | 2014-11-27 | The Penn State Research Foundation | Wound dressings and applications thereof |
-
2018
- 2018-01-10 GB GB1800385.5A patent/GB2570113B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1372604A2 (en) * | 2001-03-22 | 2004-01-02 | Battelle Memorial Institute | Manufacturing dissolvable dosage forms |
US20120148493A1 (en) * | 2009-03-16 | 2012-06-14 | Justus-Liebig-Universitat Giessen | Composite Materials Loaded with Therapeutic and Diagnostic Agents Comprising Polymer Nanoparticles and Polymer Fibers |
WO2014190038A2 (en) * | 2013-05-22 | 2014-11-27 | The Penn State Research Foundation | Wound dressings and applications thereof |
Also Published As
Publication number | Publication date |
---|---|
GB2570113A (en) | 2019-07-17 |
GB201800385D0 (en) | 2018-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA186677S (en) | Drug delivery device | |
IL291415A (en) | Drug delivery device | |
IL291155A (en) | Drug delivery device | |
IL291004A (en) | Drug delivery device | |
EP3463228A4 (en) | Intraocular drug delivery | |
IL275633A (en) | Drug delivery mechanism | |
IL291295A (en) | Drug delivery device | |
IL276784A (en) | Drug delivery systems | |
IL272278B1 (en) | Local disinfection for prefilled drug delivery system | |
EP3826589A4 (en) | Ophthalmic device for drug delivery | |
IL262062A (en) | Implantable ocular drug delivery devices | |
EP3621656A4 (en) | Ocular drug delivery formulation | |
EP3846885B8 (en) | Medicament delivery device | |
IL280184A (en) | Drug delivery devices | |
IL291154A (en) | Drug delivery device | |
HUE057487T2 (en) | Drug delivery system | |
EP3801703A4 (en) | Tissue integrated drug delivery system | |
GB201807040D0 (en) | Drug delivery | |
IL274920A (en) | Maytansinoid-based drug delivery systems | |
EP3720422C0 (en) | Liposomal system for drug delivery | |
GB201721832D0 (en) | Ocular drug delivery | |
EP3609508A4 (en) | Drug delivery system for the delivery of antiviral agents | |
EP3888693A4 (en) | Drug delivery system using solution | |
SG11202005291WA (en) | Priming system for drug delivery device | |
GB2570113B (en) | Ocular drug delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20220616 |